Literature DB >> 34486074

Diagnostic magnetic resonance imaging biomarkers for facioscapulohumeral muscular dystrophy identified by machine learning.

Mauro Monforte1, Sara Bortolani2, Eleonora Torchia2, Lara Cristiano3, Francesco Laschena3, Tommaso Tartaglione3,4, Enzo Ricci5,6, Giorgio Tasca2.   

Abstract

BACKGROUND: The diagnosis of facioscapulohumeral muscular dystrophy (FSHD) can be challenging in patients not displaying the classical phenotype or with atypical clinical features. Despite the identification by magnetic resonance imaging (MRI) of selective patterns of muscle involvement, their specificity and added diagnostic value are unknown.
METHODS: We aimed to identify the radiological features more useful to distinguish FSHD from other myopathies and test the diagnostic accuracy of MRI. A retrospective cohort of 295 patients (187 FSHD, 108 non-FSHD) studied by upper and lower-limb muscle MRI was analyzed. Scans were evaluated for the presence of 15 radiological features. A random forest machine learning algorithm was used to identify the most relevant for FSHD diagnosis. Different patterns were created by their combination and diagnostic accuracy of each of them was tested.
RESULTS: The combination of trapezius involvement and bilateral subscapularis muscle sparing achieved the best diagnostic accuracy (0.89, 95% Confidence Interval [0.85-0.92]) with 0.90 [0.85-0.94] sensitivity and 0.88 [0.80-0.93] specificity. This pattern correctly identified 91% atypical FSHD patients of our cohort. The combination of trapezius involvement, bilateral subscapularis and iliopsoas sparing and asymmetric involvement of upper and lower-limb muscles was pathognomonic for FSHD, yielding a specificity of 0.99 [0.95-1.00].
CONCLUSIONS: We identified MRI patterns that showed a high diagnostic power in promptly discriminating FSHD from other muscle disorders, with comparable performance irrespective of typical or atypical clinical features. Upper girdle in addition to lower-limb muscle imaging should be extensively implemented in the diagnostic workup to support or exclude a diagnosis of FSHD.
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Biomarkers; Facioscapulohumeral muscular dystrophy; Machine learning; Muscle MRI

Mesh:

Substances:

Year:  2021        PMID: 34486074     DOI: 10.1007/s00415-021-10786-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  25 in total

1.  A unifying genetic model for facioscapulohumeral muscular dystrophy.

Authors:  Richard J L F Lemmers; Patrick J van der Vliet; Rinse Klooster; Sabrina Sacconi; Pilar Camaño; Johannes G Dauwerse; Lauren Snider; Kirsten R Straasheijm; Gert Jan van Ommen; George W Padberg; Daniel G Miller; Stephen J Tapscott; Rabi Tawil; Rune R Frants; Silvère M van der Maarel
Journal:  Science       Date:  2010-08-19       Impact factor: 47.728

Review 2.  Facioscapulohumeral muscular dystrophy.

Authors:  George W Padberg; Baziel Gm van Engelen
Journal:  Curr Opin Neurol       Date:  2009-10       Impact factor: 5.710

3.  Diagnosis by sequencing: correction of misdiagnosis from FSHD2 to LGMD2A by whole-exome analysis.

Authors:  Andreas Leidenroth; Hanne Sørmo Sorte; Gregor Gilfillan; Melanie Ehrlich; Robert Lyle; Jane E Hewitt
Journal:  Eur J Hum Genet       Date:  2012-02-29       Impact factor: 4.246

4.  Patients with a phenotype consistent with facioscapulohumeral muscular dystrophy display genetic and epigenetic heterogeneity.

Authors:  Sabrina Sacconi; Pilar Camaño; Jessica C de Greef; Richard J L F Lemmers; Leonardo Salviati; Pascal Boileau; Adolfo Lopez de Munain Arregui; Silvère M van der Maarel; Claude Desnuelle
Journal:  J Med Genet       Date:  2011-10-07       Impact factor: 6.318

Review 5.  Genetic and epigenetic contributors to FSHD.

Authors:  Lucia Daxinger; Stephen J Tapscott; Silvère M van der Maarel
Journal:  Curr Opin Genet Dev       Date:  2015-09-07       Impact factor: 5.578

6.  Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy.

Authors:  Isabella Scionti; Francesca Greco; Giulia Ricci; Monica Govi; Patricia Arashiro; Liliana Vercelli; Angela Berardinelli; Corrado Angelini; Giovanni Antonini; Michelangelo Cao; Antonio Di Muzio; Maurizio Moggio; Lucia Morandi; Enzo Ricci; Carmelo Rodolico; Lucia Ruggiero; Lucio Santoro; Gabriele Siciliano; Giuliano Tomelleri; Carlo Pietro Trevisan; Giuliana Galluzzi; Woodring Wright; Mayana Zatz; Rossella Tupler
Journal:  Am J Hum Genet       Date:  2012-04-06       Impact factor: 11.025

7.  Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine.

Authors:  Rabi Tawil; John T Kissel; Chad Heatwole; Shree Pandya; Gary Gronseth; Michael Benatar
Journal:  Neurology       Date:  2015-07-28       Impact factor: 9.910

8.  Atypical onset in a series of 122 cases with FacioScapuloHumeral Muscular Dystrophy.

Authors:  Ebe Pastorello; Michelangelo Cao; Carlo P Trevisan
Journal:  Clin Neurol Neurosurg       Date:  2011-11-12       Impact factor: 1.876

9.  Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy.

Authors:  Lucia Ruggiero; Fabiano Mele; Fiore Manganelli; Dario Bruzzese; Giulia Ricci; Liliana Vercelli; Monica Govi; Antonio Vallarola; Silvia Tripodi; Luisa Villa; Antonio Di Muzio; Marina Scarlato; Elisabetta Bucci; Giovanni Antonini; Lorenzo Maggi; Carmelo Rodolico; Giuliano Tomelleri; Massimiliano Filosto; Stefano Previtali; Corrado Angelini; Angela Berardinelli; Elena Pegoraro; Maurizio Moggio; Tiziana Mongini; Gabriele Siciliano; Lucio Santoro; Rossella Tupler
Journal:  JAMA Netw Open       Date:  2020-05-01

10.  A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes.

Authors:  Giulia Ricci; Lucia Ruggiero; Liliana Vercelli; Francesco Sera; Ana Nikolic; Monica Govi; Fabiano Mele; Jessica Daolio; Corrado Angelini; Giovanni Antonini; Angela Berardinelli; Elisabetta Bucci; Michelangelo Cao; Maria Chiara D'Amico; Grazia D'Angelo; Antonio Di Muzio; Massimiliano Filosto; Lorenzo Maggi; Maurizio Moggio; Tiziana Mongini; Lucia Morandi; Elena Pegoraro; Carmelo Rodolico; Lucio Santoro; Gabriele Siciliano; Giuliano Tomelleri; Luisa Villa; Rossella Tupler
Journal:  J Neurol       Date:  2016-04-28       Impact factor: 4.849

View more
  2 in total

1.  Non-myogenic mesenchymal cells contribute to muscle degeneration in facioscapulohumeral muscular dystrophy patients.

Authors:  Lorena Di Pietro; Flavia Giacalone; Elvira Ragozzino; Valentina Saccone; Federica Tiberio; Marco De Bardi; Mario Picozza; Giovanna Borsellino; Wanda Lattanzi; Enrico Guadagni; Sara Bortolani; Giorgio Tasca; Enzo Ricci; Ornella Parolini
Journal:  Cell Death Dis       Date:  2022-09-16       Impact factor: 9.685

Review 2.  Update on the Molecular Aspects and Methods Underlying the Complex Architecture of FSHD.

Authors:  Valerio Caputo; Domenica Megalizzi; Carlo Fabrizio; Andrea Termine; Luca Colantoni; Carlo Caltagirone; Emiliano Giardina; Raffaella Cascella; Claudia Strafella
Journal:  Cells       Date:  2022-08-29       Impact factor: 7.666

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.